Why Is Zimmer (ZBH) Up 1.8% Since Last Earnings Report?
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research9/4/2026Positive
ZBH
Zimmer Biomet Holdings IncNYSEHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$18.71B
P/E Ratio
23.80
EPS
$4.12
Beta
0.47
52W High
$106.03
52W Low
$78.91
50-Day MA
$94.93
200-Day MA
$91.36
Dividend Yield
0.97%
Profit Margin
9.48%
Forward P/E
11.00
PEG Ratio
0.63
About Zimmer Biomet Holdings Inc
Zimmer Biomet is a publicly traded medical device company. The company is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.
Fundamentals
| Revenue (TTM) | $8.51B |
| Gross Profit (TTM) | $5.95B |
| EBITDA | $2.56B |
| Operating Margin | 18.00% |
| Return on Equity | 6.41% |
| Return on Assets | 3.96% |
| Revenue/Share (TTM) | $43.50 |
| Book Value | $66.23 |
| Price-to-Book | 1.50 |
| Price-to-Sales (TTM) | 2.20 |
| EV/Revenue | 3.061 |
| EV/EBITDA | 11.17 |
| Quarterly Earnings Growth (YoY) | 33.80% |
| Quarterly Revenue Growth (YoY) | 4.80% |
| Shares Outstanding | $190.74M |
| Float | $190.12M |
| % Insiders | 0.16% |
| % Institutions | 111.48% |
Historical Volatility
HV 10-Day
15.73%
HV 20-Day
20.83%
HV 30-Day
25.46%
HV 60-Day
31.70%
HV Rank
46.8%
Volatility is currently contracting
Analyst Ratings
Consensus ($107.57 target)
3
Strong Buy6
Buy18
HoldLatest News
Zimmer Biomet - Showing Signs Of Life
Zimmer Biomet is seeing structural constant currency sales growth appear. This is driven by transformation factors, R&D and M&A efforts. Earnings growth is lagging sales, but this hopefully should catch up soon.
Seeking Alpha9/1/2026Positive
Why Zimmer Biomet (ZBH) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research8/31/2026Positive
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2026
WARSAW, Ind., Aug. 28, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2026.
PRNewsWire8/28/2026Neutral
Is Zimmer Biomet Stock Worth Retaining in Your Portfolio Now?
ZBH's growth outlook is backed by healthy procedure demand and Z1, HAMMR and OrthoGrid adoption, though debt and competition remain concerns.
Zacks Investment Research8/20/2026Neutral
Here's Why Zimmer Biomet (ZBH) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research8/10/2026Positive
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research8/6/2026Positive
Zimmer Biomet Holdings, Inc. (ZBH) Q2 2026 Earnings Call Transcript
Zimmer Biomet Holdings, Inc. (ZBH) Q2 2026 Earnings Call Transcript
Seeking Alpha8/5/2026Neutral
ZBH's Q2 Earnings Beat, '26 View Raised, Stock Up in Pre-Market
ZBH beats second-quarter earnings and revenue estimates, raises its 2026 outlook and gains in pre-market despite pressure on adjusted margins.
Zacks Investment Research8/5/2026Positive
Zimmer (ZBH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Zimmer (ZBH) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks Investment Research8/5/2026Neutral
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ZBH and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 9/7/2026